microRNA in Human Disease & Development / March 2009

2 posts / 0 new
Last post
AUen's picture
microRNA in Human Disease & Development / March 2009


microRNA in Human Disease & Development

Register by January 9 and Save Up to $350!


microRNA Pathways and Mechanisms
microRNA in Human Development and Disease
microRNA Biomarkers for Diagnostics
microRNA Targets for Therapeutics
Special Focus: microRNA in Cancer

microRNA Identification, Profiling and Validation Techniques

Andreas G. Bader, Ph.D., Senior Scientist, Mirna Therapeutics, Inc.

Don A. Baldwin, Ph.D., Director, Penn Genomics Facility, University of Pennsylvania

Michele Cleary, Ph.D., Director, Biology, Rosetta Inpharmatics LLC, a wholly owned subsidiary of Merck & Co., Inc.

John P. Cogswell, Ph.D., Genetics Consultant, GlaxoSmithKline

Dalia Cohen, Ph.D., Chief Scientific Officer, Rosetta Genomics, Inc.

Christoph Eicken Ph.D., Head, Technical Services Microarrays, LC Sciences LLC

Aurora Esquela-Kerscher, Ph.D., Assistant Professor, Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School

Richard Gregory, Ph.D., Assistant Professor, Department of Biological Chemistry and Molecular Pharmacology, Harvard Stem Cell Institute, The Stem Cell Program at Children's Hospital Boston, Harvard Medical School

Qihong Huang, M.D., Ph.D., Assistant Professor, Systems Biology, Molecular and Cellular Oncogenesis Program, Wistar Institute

Jingfang Ju, Ph.D., Associate Professor and Co-Director, Translational Research Laboratory, Department of Pathology, Stony Brook University Medical Center

Marianthi Kiriakidou, M.D., Assistant Professor, Medicine, University of Pennsylvania School of Medicine

Sean Lawler, Ph.D., Assistant Professor, Neurological Surgery, Ohio State University

Harvey F. Lodish, Ph.D., Member, Whitehead Institute for Biomedical Research; Professor, Biology & Bioengineering, Massachusetts Institute of Technology

Li Ma, Ph.D., Life Sciences Research Foundation Fellow, Weinberg Lab, Whitehead Institute/Massachusetts Institute of Technology

Muthiah Manoharan, Ph.D., Vice President, Drug Discovery, Alnylam Pharmaceuticals, Inc.

Pieter Mestdagh, Ph.D., Center for Medical Genetics Ghent, Ghent University Hospital

Søren Møller, Ph.D., Vice President, Research & Development, Exiqon A/S

Mahendra S. Rao, Ph.D., Vice President, Stem Cells and Regenerative Medicine, Invitrogen

Isidore Rigoutsos, Ph.D., Manager, Bioinformatics & Pattern Discovery Group, Computational Biology Center, Deep Computing Institute, IBM Thomas J. Watson Research Center

Aldo Roccaro, M.D., Ph.D., Instructor in Medicine, Harvard Medical School

Hannele Ruohola-Baker, Ph.D., Professor, Biochemistry, University of Washington;

Aaron J. Schetter, Ph.D., M.P.H., Postdoctoral Fellow, Laboratory of Human Carcinogenesis, National Cancer Institute

Frank Slack, Ph.D., Associate Professor, Department of Molecular, Cellular and Developmental Biology, Yale University

Neil Smalheiser, M.D., Ph.D., Associate Professor, Psychiatry, University of Illinois at Chicago

Juergen Soutschek, Ph.D., Senior Director, Scientific Development, Regulus Therapeutics

Samuil Umansky, M.D., Ph.D., Chief Scientific Officer, Xenomics, Inc.

Eva van Rooij, Ph.D., Department of Molecular Biology, University of Texas Southwestern Medical Center; Director, Preclinical Research, miRagen Therapeutics, Inc.

Francois Vigneault, Ph.D., Church Laboratory, Department of Genetics, Harvard Medical School

Elena Vigorito, Ph.D., Group Leader, The Babraham Institute, UK

Eugenia Wang, Ph.D., Gheens Endowed Chair in Aging, University of Louisville

Mike Wilson, Ph.D., Senior Scientist, Asuragen, Inc.

Lin Zhang, M.D., Research Assistant Professor, Center for Research on the Early Detection & Cure of Ovarian Cancer, Center for Research on Reproduction and Women's Health, Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine

Jon Moulton
Jon Moulton's picture
I was at the microRNA in

I was at the microRNA in Human Disease and Development conference last year and it was well worth the journey.